D. Fisher

发表

Modified Magrath Regimens for Adults with Burkitt and Burkitt-Like Lymphomas: Preserved Efficacy with Decreased Toxicity

A. LaCasce, D. Neuberg, M. Shipp, 2004, Leukemia & lymphoma.

T cell-depleted allogeneic bone marrow transplantation for non-Hodgkin ’ s lymphoma

D. Neuberg, J. Ritz, P. Mauch, 1998 .

Reduced mortality following bone marrow transplantation for breast cancer with the addition of peripheral blood progenitor cells is due to a marked reduction in veno-occlusive disease of the liver

D. Berry, W. Petros, J. Vredenburgh, 1998, Bone Marrow Transplantation.

A randomized trial of recombinant human interleukin-11 following autologous bone marrow transplantation with peripheral blood progenitor cell support in patients with breast cancer.

J. Vredenburgh, J. Loewy, K. Dykstra, 1998, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Ex vivo B cell depletion using the Eligix B Cell SC system and autologous peripheral blood stem cell transplantation in patients with follicular non-Hodgkin's lymphoma

J. Friedberg, D. Neuberg, T. Spitzer, 2003, Bone Marrow Transplantation.

Thrombotic microangiopathy as a complication of high-dose chemotherapy for breast cancer.

W. Petros, J. Vredenburgh, M. Ross, 1996, Bone marrow transplantation.

Effect of total body irradiation dose escalation on outcome following T-cell-depleted allogeneic bone marrow transplantation.

J. Gribben, D. Neuberg, J. Ritz, 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

T-cell--depleted allogeneic bone marrow transplantation followed by donor lymphocyte infusion in patients with multiple myeloma: induction of graft-versus-myeloma effect.

J. Gribben, J. Ritz, R. Soiffer, 2001, Blood.

Autologous bone marrow transplantation after histologic transformation of indolent B cell malignancies.

J. Gribben, J. Friedberg, D. Neuberg, 1999, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphoma.

J. Gribben, D. Neuberg, J. Ritz, 1999, Blood.

High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission.

J. Gribben, D. Neuberg, J. Aster, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

CD6-depleted allogeneic bone marrow transplantation for acute leukemia in first complete remission.

D. Fairclough, J. Ritz, D. Fisher, 1997, Blood.

CD6+ donor marrow T-cell depletion as the sole form of graft-versus-host disease prophylaxis in patients undergoing allogeneic bone marrow transplant from unrelated donors.

J. Ritz, A. Freedman, P. Mauch, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.

D. Fairclough, J. Ritz, A. Freedman, 1997, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Cyclophosphamide, doxorubicin, vincristine, prednisone dose intensification with granulocyte colony-stimulating factor markedly depletes stem cell reserve for autologous bone marrow transplantation.

J. Gribben, D. Neuberg, J. Ritz, 1997, Blood.

Outcome after autologous and allogeneic stem cell transplantation for patients with multiple myeloma: impact of graft-versus-myeloma effect

J. Gribben, P. Richardson, J. Ritz, 2003, Bone Marrow Transplantation.

Advances in the clinical use of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor to intensify cancer chemotherapy.

W. Peters, D. Fisher, 1994, Current opinion in hematology.